πŸ‡ΊπŸ‡Έ FDA
Patent

US 6790953

Ether compounds

expired A61PA61P1/18A61P13/12

Quick answer

US patent 6790953 (Ether compounds) held by Esperion Therapeutics, Inc. expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P1/18, A61P13/12, A61P15/10, A61P25/28